Psychosocial and behavioral functioning and their relationship to seizure timing in children with benign epilepsy

Gonca Bektaş1, Uğur Tekin2, Edibe Pembegül Yıldız1

  • 1Department of Pediatric Neurology, Istanbul Faculty of Medicine, Istanbul University, Istanbul, Turkey.

Brain & Development
|February 19, 2017
PubMed

Insights

Children with benign epilepsy with centrotemporal spikes (BECTS) experiencing seizures after falling asleep may exhibit more behavioral difficulties. This study explored seizure timing and its impact on behavior in BECTS patients.

Area of Science:

  • Pediatric Neurology
  • Neuropsychology
  • Child Psychiatry

Background:

  • Benign epilepsy with centrotemporal spikes (BECTS) is associated with reported psychosocial and behavioral problems in children.
  • Specific features linking BECTS to cognitive and behavioral issues remain undefined.

Purpose of the Study:

  • To identify psychosocial and behavioral functioning in children with BECTS.
  • To investigate the relationship between seizure timing and behavioral outcomes in BECTS.

Main Methods:

  • Recruited 46 children with BECTS and 49 healthy controls (ages 7-16).
  • Classified BECTS patients into two groups based on seizure timing: morning seizures vs. sleep-related seizures.
  • Utilized Wechsler Intelligence Scale for Children-Revised and Strengths and Difficulties Questionnaire (SDQ) for evaluations.

Main Results:

  • No significant intelligence differences were found between BECTS groups and controls.
  • Children with BECTS experiencing seizures shortly after falling asleep (group 2) showed significantly higher overall stress scores on the SDQ compared to controls.
  • Children with morning seizures only (group 1) did not differ from controls in behavioral scores.

Conclusions:

  • Seizure timing is a critical factor in BECTS-related behavioral issues.
  • BECTS patients with seizures shortly after falling asleep may be at higher risk for behavioral difficulties.
Abstract

Related Concept Videos

Epilepsy and Seizures: Overview01:24

Epilepsy and Seizures: Overview

Epilepsy is a chronic neurological disease marked by recurrent, unpredictable seizures. These seizures are caused by abnormal electrical discharges in the brain, leading to behavior, sensation, or consciousness alterations. They can also cause transient impairment of awareness, interfering with daily activities.
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
1.5K
Seizures: Classification01:13

Seizures: Classification

Epilepsy is primarily characterized by unpredictable seizures, either provoked by an identifiable factor, such as injury or illness, or unprovoked, occurring spontaneously without apparent cause.
Seizures are typically classified into two main categories: focal and generalized seizures.
Focal Seizures
Focal seizures originate from specific regions of the brain. These seizures are further sub-classified into two types:
1.9K
Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein01:20

Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein

Antiepileptic drugs, such as levetiracetam (Keppra) and brivaracetam (Briviact), have emerged as crucial tools in managing epilepsy. These medications exert their therapeutic effects by targeting the synaptic vesicle protein SV2A, a transmembrane glycoprotein primarily found in the brain.
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
1.0K